Keywords: epigenomics, 3rd-qtr, sales, beat, targets, molecular, diagnostics

Epigenomics 3rd-qtr sales beat targets

Article | 15 November 2004

Print This

Molecular diagnostics group Epigenomics saw its sales for the third quarter of 2004, which are mainly derived from collaborations with Roche, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in